Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients.

Overbeek KA, Krak NC, Pieters IC, Smits MM, Bent RM, Vendrik KEW, Tonneijck L, Muskiet MHA, van Raalte DH, Bruno MJ, Cahen DL.

Pancreas. 2020 Jan;49(1):e5-e7. doi: 10.1097/MPA.0000000000001444. No abstract available.


Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.

Buitenwerf E, Korteweg T, Visser A, Haag CMSC, Feelders RA, Timmers HJLM, Canu L, Haak HR, Bisschop PHLT, Eekhoff EMW, Corssmit EPM, Krak NC, Rasenberg E, van den Bergh J, Stoker J, Greuter MJW, Dullaart RPF, Links TP, Kerstens MN.

Eur J Endocrinol. 2018 May;178(5):431-437. doi: 10.1530/EJE-18-0006. Epub 2018 Feb 21.


Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.

Konings IC, Harinck F, Poley JW, Aalfs CM, van Rens A, Krak NC, Wagner A, Nio CY, Sijmons RH, van Dullemen HM, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ; Dutch Research Group on Pancreatic Cancer Surveillance in High-Risk Individuals.

Pancreas. 2017 Jan;46(1):28-34.


Small-bowel Surveillance in Patients With Peutz-Jeghers Syndrome: Comparing Magnetic Resonance Enteroclysis and Double Balloon Enteroscopy.

Goverde A, Korsse SE, Wagner A, van Leerdam ME, Krak NC, Stoker J, van Buuren HR, Hofstra RM, Bruno MJ, Dewint P, Dekker E, Spaander MC.

J Clin Gastroenterol. 2017 Apr;51(4):e27-e33. doi: 10.1097/MCG.0000000000000592.


Liver Contrast-Enhanced Ultrasound Improves Detection of Liver Metastases in Patients with Pancreatic or Periampullary Cancer.

Taimr P, Jongerius VL, Pek CJ, Krak NC, Hansen BE, Janssen HL, Metselaar HJ, van Eijck CH.

Ultrasound Med Biol. 2015 Dec;41(12):3063-9. doi: 10.1016/j.ultrasmedbio.2015.06.019. Epub 2015 Oct 1.


Cytopathological Analysis of Cyst Fluid Enhances Diagnostic Accuracy of Mucinous Pancreatic Cystic Neoplasms.

Utomo WK, Braat H, Bruno MJ, van Eijck CH, Groot Koerkamp B, Krak NC, van de Vreede A, Fuhler GM, Peppelenbosch MP, Biermann K.

Medicine (Baltimore). 2015 Jun;94(24):e988. doi: 10.1097/MD.0000000000000988.


A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ; Dutch research group on pancreatic cancer surveillance in high-risk individuals.

Gut. 2016 Sep;65(9):1505-13. doi: 10.1136/gutjnl-2014-308008. Epub 2015 May 18.


Induction chemotherapy followed by surgery for advanced oesophageal cancer.

Toxopeus EL, Talman S, van der Gaast A, Spaander VM, van Rij CM, Krak NC, Biermann K, Tilanus HW, Mathijssen RH, van Lanschot JJ, Wijnhoven BP.

Eur J Surg Oncol. 2015 Mar;41(3):323-32. doi: 10.1016/j.ejso.2014.11.043. Epub 2014 Dec 3.


Partial volume correction strategies for quantitative FDG PET in oncology.

Hoetjes NJ, van Velden FH, Hoekstra OS, Hoekstra CJ, Krak NC, Lammertsma AA, Boellaard R.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1679-87. doi: 10.1007/s00259-010-1472-7. Epub 2010 Apr 27.


Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology.

Emmering J, Krak NC, Van der Hoeven JJ, Spreeuwenberg MD, Twisk JW, Meijer S, Pinedo HM, Hoekstra OS.

Ann Oncol. 2008 Sep;19(9):1573-7. doi: 10.1093/annonc/mdn185. Epub 2008 Jun 13.


Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.

Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA.

Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):294-301. Epub 2004 Oct 15. Erratum in: Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1245.


Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA.

J Nucl Med. 2004 Sep;45(9):1519-27.


Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Krak NC, Hoekstra OS, Lammertsma AA.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S103-11. Epub 2004 Apr 22. Review.


18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.

van der Hoeven JJ, Krak NC, Hoekstra OS, Comans EF, Boom RP, van Geldere D, Meijer S, van der Wall E, Buter J, Pinedo HM, Teule GJ, Lammertsma AA.

J Clin Oncol. 2004 Apr 1;22(7):1253-9.


Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.

Krak NC, van der Hoeven JJ, Hoekstra OS, Twisk JW, van der Wall E, Lammertsma AA.

Eur J Nucl Med Mol Imaging. 2003 May;30(5):674-81. Epub 2003 Mar 15.


Supplemental Content

Support Center